Corrigendum to “Exploring the interactions between engineered nanomaterials and immune cells at 3D nano-bio interfaces to discover potent nano-adjuvants” [Nanomed.: Nanotechnol. Biol. Med. 21C (2019) 102037]

IF 4.2 2区医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL

Nanomedicine : nanotechnology, biology, and medicine Pub Date : 2025-01-01 DOI:10.1016/j.nano.2024.102800

Ronglin Ma MSc , Huizhen Zheng PhD , Qi Liu PhD , Di Wu BS , Wei Li MSc , Shujuan Xu BS , Xiaoming Cai PhD , Ruibin Li PhD

引用次数: 0

查看原文本刊更多论文

“在3D纳米生物界面上探索工程纳米材料和免疫细胞之间的相互作用，以发现有效的纳米佐剂”的勘误表[Nanomed]。: Nanotechnol。医学杂志。医学通报，2016,(5):357 - 357。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nanomedicine : nanotechnology, biology, and medicine 工程技术-纳米科技

CiteScore

11.10

自引率

0.00%

发文量

133

审稿时长

42 days

期刊介绍： The mission of Nanomedicine: Nanotechnology, Biology, and Medicine (Nanomedicine: NBM) is to promote the emerging interdisciplinary field of nanomedicine. Nanomedicine: NBM is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life and health sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases.